Vaxxinity (NASDAQ:VAXX) Upgraded by Zacks Investment Researc

Vaxxinity (NASDAQ:VAXX – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Wednesday, Zacks.com reports. According to Zacks, “Vaxxinity Inc. is a biotechnology company pioneering a new class of immunotherapeutic vaccines to democratize health. Vaxxinity Inc. is based in DALLAS, Texas. “ Several […]

Related Keywords

United States , Dallas , Texas , America , , Vaxxinity Inc , Jefferies Financial Group , Geode Capital Management , Goldman Sachs Group Inc , Virtu Financial , Zacks Investment Research , Millennium Management , Get Rating , Financial Group , Sachs Group , Capital Management , Adage Capital Partners , Vaxxinity , Nasdaq Vaxx , Vaxx , Medical , Upgrade ,